The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010

Frank Lichtenberg

Journal of Human Capital, 2014, vol. 8, issue 4, 432 - 480

Abstract: I investigate whether diseases subject to more rapid pharmaceutical innovation experienced greater declines in Americans' disability days and use of medical services during the period 1997-2010, controlling for several other factors, using data from the Medical Expenditure Panel Survey. The mean number of work loss days, school loss days, and hospital admissions declined more rapidly among medical conditions with larger increases in the mean number of new (post-1990) prescription drugs consumed. The value of reductions in work loss days and hospital admissions attributable to pharmaceutical innovation is estimated to be three times as large as the cost of new drugs consumed.

Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (9)

Downloads: (external link)
http://dx.doi.org/10.1086/679110 (application/pdf)
http://dx.doi.org/10.1086/679110 (text/html)
Access to the online full text or PDF requires a subscription.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ucp:jhucap:doi:10.1086/679110

Access Statistics for this article

More articles in Journal of Human Capital from University of Chicago Press
Bibliographic data for series maintained by Journals Division ().